NEW YORK (GenomeWeb News) - Millipore and Guava Technologies have agreed to integrate their flow cytometry instrumentation, reagents, and support capabilities in an effort to target cell biologists, the companies said today.
Under the terms of the partnership, Millipore will develop co-branded reagent kits for Guava's flow cytometers. Millipore also has exclusive rights to distribute and service Guava's non-clinical instrumentation within certain regions of North America, Europe, and Asia.
The companies said they also plan to “work together to develop a new generation of instrumentation with enhanced performance and functionality.”
The first co-branded products under the partnership will be released in July.
Guava specializes in micro-capillary flow cytometry systems, which require smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and run than traditional flow cytometry technology, according to the company.